Vis enkel innførsel

dc.contributor.authorTernullo, Selenia
dc.contributor.authorde Weerd, Louis
dc.contributor.authorHolsæter, Ann Mari
dc.contributor.authorFlaten, Gøril Eide
dc.contributor.authorSkalko-Basnet, Natasa
dc.date.accessioned2018-03-26T12:41:08Z
dc.date.available2018-03-26T12:41:08Z
dc.date.issued2017-09-12
dc.description.abstractPhospholipid-based nanocarriers are attractive drug carriers for improved local skin therapy. In the present study, the recently developed isolated perfused human skin flap (IPHSF) model was used to directly compare the skin penetration enhancing potential of the three commonly used nanocarriers, namely conventional liposomes (CLs), deformable liposomes (DLs) and solid lipid nanoparticles (SLNs). Two fluorescent markers, calcein (hydrophilic) or rhodamine (lipophilic), were incorporated individually in the three nanosystems. The nanocarrier size ranged between 200 and 300 nm; the surface charge and entrapment efficiency for both markers were dependent on the lipid composition and the employed surfactant. Both carrier-associated markers could not penetrate the full thickness human skin, confirming their suitability for dermal drug delivery. CLs exhibited higher retention of both markers on the skin surface compared to DLs and SLNs, indicating a depo formation. DLs and SLNs enabled the deeper penetration of the two markers into the skin layers. In vitro and ex vivo skin penetration studies performed on the cellophane membrane and full thickness pig/human skin, respectively, confirmed the findings. In conclusion, efficient dermal drug delivery can be achieved by optimization of a lipid nanocarrier on the suitable skin-mimicking model to assure system’s accumulation in the targeted skin layer.en_US
dc.descriptionPublished version available in <a href=http://dx.doi.org/10.1016/j.ejpb.2017.09.006> European journal of pharmaceutics and biopharmaceutics 2017, 121:14-23. </a>en_US
dc.identifier.citationTernullo, S., de Weerd, L., Holsæter, A. M., Flaten, G. E., Skalko-Basnet, N. (2017). Going skin deep: a direct comparison of penetration potential of lipid-based nanovesicles on the isolated perfused human skin flap model. European journal of pharmaceutics and biopharmaceutics. 121:14-23en_US
dc.identifier.cristinIDFRIDAID 1494019
dc.identifier.doi10.1016/j.ejpb.2017.09.006
dc.identifier.issn0939-6411
dc.identifier.issn1873-3441
dc.identifier.urihttps://hdl.handle.net/10037/12447
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.journalEuropean journal of pharmaceutics and biopharmaceutics
dc.rights.accessRightsopenAccessen_US
dc.subjectLocal skin therapyen_US
dc.subjectPhospholipid-based nanosystemsen_US
dc.subjectSkin penetrationen_US
dc.subjectHuman skinen_US
dc.subjectLiposomesen_US
dc.subjectIsolated perfused human flapen_US
dc.subjectVDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Farmakologi: 728en_US
dc.subjectVDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Pharmacology: 728en_US
dc.titleGoing skin deep: a direct comparison of penetration potential of lipid-based nanovesicles on the isolated perfused human skin flap modelen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel